Related Experiment Videos
Coronary atherosclerosis stabilization: an achievable goal
1Department of Medicine, University of Washington Medical Center, Seattle 98195, USA.
Atherosclerosis
|December 1, 1995
Summary
Lipid-altering strategies can slow coronary artery disease progression and reduce cardiac events by stabilizing vulnerable atherosclerotic plaques. Identifying high-risk individuals is crucial for effective treatment and prevention of heart attacks.
Area of Science:
- Cardiology
- Vascular Biology
- Preventive Medicine
Background:
- Coronary atherosclerotic plaques can cause angina, myocardial infarction, or sudden death.
- Rupture-prone plaques are lipid-rich with thin fibrous caps, often appearing mild angiographically.
- Current treatments primarily manage symptoms or salvage myocardium post-infarction, rather than preventing plaque rupture.
Purpose of the Study:
- To evaluate the impact of lipid-altering strategies on coronary artery disease progression and cardiac events in humans.
- To investigate whether modifying lipid levels can stabilize vulnerable atherosclerotic plaques.
Main Methods:
- Analysis of sixteen published angiographic regression studies.
- Review of clinical trial data assessing lipid-altering therapies for coronary artery disease.
Main Results:
- Consistently favorable alteration of lipid levels retards coronary artery disease progression.
- Lipid modification markedly reduces cardiac events.
- Observed event reduction exceeds changes seen in angiographic disease, suggesting plaque stabilization.
Conclusions:
- Lipid-altering strategies are effective in managing coronary artery disease by promoting plaque stabilization.
- Identifying patients with vulnerable plaques is critical for targeted and effective treatment.
- Early intervention with lipid modification can prevent severe cardiac events.